Search Count: 18
 |
Organism: Clostridioides difficile, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2025-07-09 Classification: TRANSFERASE,TOXIN/IMMUNE SYSTEM |
 |
Structure-Based Engineering Of A Highly Immunogenic, Conformationally Stabilized Fimh Antigen For A Urinary Tract Infection Vaccine
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-02-05 Classification: CELL ADHESION Ligands: NAG |
 |
Cryo-Em Structure Of E. Coli Fimh Lectin Domain Bound To Fabs 440-2 And 454-3
Organism: Mus musculus, Escherichia coli
Method: ELECTRON MICROSCOPY Release Date: 2025-02-05 Classification: CELL ADHESION,SUGAR BINDING PROTEIN |
 |
Cryo-Em Structure Of E. Coli Fimh Lectin Domain Bound To Fabs 329-2 And 454-3
Organism: Mus musculus, Escherichia coli
Method: ELECTRON MICROSCOPY Release Date: 2024-12-18 Classification: CELL ADHESION/IMMUNE SYSTEM |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2024-12-04 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Structure Of Sars-Cov-2 Mpro Mutant (S144A) In Complex With Nirmatrelvir (Pf-07321332)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: 4WI |
 |
Structure Of Sars-Cov-2 Mpro Mutant (A173V) In Complex With Nirmatrelvir (Pf-07321332)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: 4WI |
 |
Structure Of Sars-Cov-2 Mpro Mutant (A173V,T304I)) In Complex With Nirmatrelvir (Pf-07321332)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.42 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: 4WI |
 |
Structure Of Sars-Cov-2 Mpro Mutant (T21I,S144A,T304I) In Complex With Nirmatrelvir (Pf-07321332)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: 4WI |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN, HYDROLASE |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.42 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN, HYDROLASE Ligands: HOH |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4W8 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4WI |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4YG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4WI |
 |
Organism: Staphylococcus aureus, Mus musculus
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2016-09-21 Classification: Transport protein/Immune System Ligands: FE, GOL |
 |
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2013-07-17 Classification: TRANSPORT PROTEIN Ligands: MN |
 |
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2011-05-04 Classification: CELL ADHESION Ligands: MG |